Skip to content
— CH. 1 · VIRAL ORIGINS AND VARIETIES —

Common cold

~3 min read · Ch. 1 of 7
7 sections
  • Over 200 distinct virus strains cause the common cold, making it a biological puzzle rather than a single disease. Rhinoviruses account for 30 to 80 percent of all cases and belong to the picornavirus family with 99 known serotypes. Coronaviruses appear as another major culprit, displaying a halo or crown-like shape under an electron microscope. Adenoviruses, enteroviruses, parainfluenza viruses, and respiratory syncytial virus round out the most frequent offenders. Sometimes more than one virus infects a person simultaneously, complicating diagnosis and treatment efforts. The viral cause remains unknown in 20 to 30 percent of documented cold cases.

  • The virus spreads through airborne droplets generated by breathing, talking, or singing during routine activities. Direct contact with infected nasal secretions transfers the pathogen to hands that then touch eyes or noses. Contaminated objects called fomites allow rhinoviruses to survive for over 18 hours in the environment before infection occurs. Child care facilities and schools create high-risk zones due to close proximity among children with developing immunity. Poor hygiene practices amplify transmission rates within these crowded settings. People remain contagious throughout the duration of their symptoms, spreading the virus to family members who bring it home from daycare.

  • A sore throat appears in about 40 percent of all cold cases while coughing affects roughly half of patients. Muscle aches occur in approximately 50 percent of infections alongside fatigue and headache. Symptoms typically peak two to four days after onset but may persist for up to three weeks in some individuals. The body's immune response generates most symptoms rather than direct tissue destruction by the viruses themselves. Rhinovirus binds to human cells via ICAM-1 receptors triggering inflammatory mediators that produce congestion and discharge. Respiratory syncytial virus causes actual damage to the nasal epithelium unlike other common cold agents.

  • Hand washing remains the primary method for reducing viral spread among populations worldwide. Face masks offer some protection when worn around infected people though evidence for social distancing remains insufficient. Indoor air ventilation and HEPA filters provide reliable defense against aerosolized cold-laden particles. No vaccine exists because the viruses mutate rapidly and exist in over 200 different forms. Vaccination efforts face high probability of failure due to this extreme genetic diversity. Isolation or quarantine measures prove impractical given how widespread and non-specific the symptoms remain across communities.

  • Zinc supplements taken within 24 hours of symptom onset can shorten cold duration by up to 33 percent. Some zinc remedies applied inside the nose cause loss of smell as a side effect. Antibiotics fail completely against viral infections yet remain frequently prescribed despite causing overall harm. Over-the-counter cough medicines lack proven effectiveness and carry potential risks especially for children under six years old. Pain medications like ibuprofen help manage discomfort while acetaminophen's benefit remains unclear. Nasal decongestants show small benefits for adults but safety data for children remains uncertain.

  • The Common Cold Unit opened in the United Kingdom in 1946 under the Medical Research Council. Rhinovirus was discovered there in 1956 marking a pivotal moment in understanding the disease. The unit demonstrated that interferon treatment during incubation phases offered partial protection against infection. Zinc gluconate lozenges became the only successful treatment developed during the unit's existence before its closure in 1989. Historical records from the Egyptian Ebers papyrus describe cold symptoms written before the 16th century BCE. The name cold entered common usage in the 16th century due to perceived similarities with weather exposure effects.

  • Adults experience two to three colds annually while school children may contract up to twelve infections per year. The basic reproduction number ranges between 2 and 3 meaning each infected person typically spreads it to others. Winter months see increased prevalence though the exact reason for seasonality remains undetermined by science. In the United States alone annual physician visits reach 75 to 100 million costing $7.7 billion conservatively. Americans spend $2.9 billion on over-the-counter drugs plus another $400 million on prescription medicines. Work loss exceeds $20 billion yearly accounting for 40 percent of all time lost from employment nationwide.

Up Next

Continue Browsing

Common questions

What viruses cause the common cold?

Over 200 distinct virus strains cause the common cold, with rhinoviruses accounting for 30 to 80 percent of all cases. Coronaviruses, adenoviruses, enteroviruses, parainfluenza viruses, and respiratory syncytial virus also serve as frequent offenders.

How does the common cold spread between people?

The virus spreads through airborne droplets generated by breathing, talking, or singing during routine activities. Direct contact with infected nasal secretions transfers the pathogen to hands that then touch eyes or noses, while contaminated objects called fomites allow rhinoviruses to survive for over 18 hours in the environment before infection occurs.

When do symptoms of the common cold peak?

Symptoms typically peak two to four days after onset but may persist for up to three weeks in some individuals. A sore throat appears in about 40 percent of all cold cases while coughing affects roughly half of patients.

Why is there no vaccine for the common cold?

No vaccine exists because the viruses mutate rapidly and exist in over 200 different forms. Vaccination efforts face high probability of failure due to this extreme genetic diversity.

What treatments shorten the duration of a common cold?

Zinc supplements taken within 24 hours of symptom onset can shorten cold duration by up to 33 percent. Zinc gluconate lozenges became the only successful treatment developed during the Common Cold Unit's existence before its closure on the 1st of January 1990.